Select Medical's 15min chart shows KDJ Death Cross, Bearish Marubozu formation.

According to the 15-minute chart for Select Medical, there has been a significant development. The stock's momentum has shifted downwards, as evidenced by the KDJ Death Cross and Bearish Marubozu at 08/15/2025 15:00. This suggests that the stock price is likely to continue decreasing, with sellers dominating the market and reinforcing bearish momentum.

According to the 15-minute chart for Select Medical, a significant development has occurred. The stock's momentum has shifted downwards, as evidenced by the KDJ Death Cross and Bearish Marubozu at 15:00 on August 15, 2025. This suggests that the stock price is likely to continue decreasing, with sellers dominating the market and reinforcing bearish momentum.

The KDJ Death Cross, which occurs when the K line crosses below the D line, signals a change in market sentiment from buyers to sellers. This crossover typically indicates a potential for further price depreciation [1]. Additionally, the Bearish Marubozu, a candlestick pattern characterized by a large red candle with no upper wick and a lower wick, indicates strong selling pressure, where buyers were unable to push prices back up at any point during the session [2].

The narrowing of Bollinger Bands on the 15-minute chart further supports this bearish trend. A decrease in price volatility, as indicated by the narrowing of Bollinger Bands, often precedes significant price movements [1]. This development comes amidst a broader market trend where select shares across the market are currently trading in an overbought zone following a sharp rally from the April-month lows [1].

Investors are advised to exercise caution and diligent risk management in the face of these bearish indicators. The market's current state of paralysis, awaiting the quarterly results of major companies such as ICICI Bank, HDFC Bank, and Reliance Industries, scheduled for release this weekend, may further exacerbate volatility [3].

Mizuho lowered its price target on Select Medical (NYSE: SEM) to $18.00 from $21.00, citing disappointing second-quarter 2025 earnings and continued pressure from the Medicare high-cost outlier threshold and the 20% transmittal rule [3]. Despite these challenges, the firm maintained its Outperform rating, expecting the inpatient rehabilitation (IRF) segment to continue driving growth for the company.

References:
[1] https://www.ainvest.com/news/select-medical-15min-chart-triggers-kdj-death-cross-bearish-marubozu-2508/
[2] https://www.investors.com/news/technology/inspire-medical-systems-stock-inspire-medical-systems-earnings-q2-2025/
[3] https://za.investing.com/news/analyst-ratings/mizuho-lowers-select-medical-holdings-stock-price-target-on-ltch-segment-pressure-93CH-3831403